{"transactions":[{"id":4620226,"issuer":{"id":7276,"kind":"organization","name":"Tevogen Inc.","symbol":"TVGN"},"owners":[{"id":31015,"kind":"person","name":"Desai Kirti","position":1,"cik":"0002011765","reported_name":"Desai Kirti","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-16T23:54:02.000Z","date":"2026-09-14","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock under the Tevogen Inc. (the \"Company\") 2024 Omnibus Incentive Plan, which will vest only upon written certification by the Company's Board of Directors that the Company has achieved $1.0 billion in aggregate revenue during the period from September 14, 2026 through September 30, 2031 (the \"Performance Period\"). The shares will automatically be forfeited in the event such revenue threshold is not met during Performance Period, upon termination of the Reporting Person's service with the Company for any reason, if it is determined that the Reporting Person has engaged in certain misconduct or competitive activities with the Company, in the event of transfer or attempted transfer prior to vesting, or if the award is not assumed in connection with a change in control."}],"balance_after":992983,"source":{"system":"sec-edgar","filing":"0001123292-26-001312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011765/000112329226001312/form4.xml","form_type":"4"}},{"id":711268,"issuer":{"id":7276,"kind":"organization","name":"Tevogen Inc.","symbol":"TVGN"},"owners":[{"id":31015,"kind":"person","name":"Desai Kirti","position":1,"cik":"0002011765","reported_name":"Desai Kirti","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-10T17:30:18.000Z","date":"2026-07-10","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan, which vests in three equal installments upon the earlier of each of (i) the first anniversary of the grant date and the Issuer having aggregate revenue of $50 million since the grant date, (ii) the second anniversary of the grant date and the Issuer having aggregate revenue of $100 million since the grant date, and (ii) the third anniversary of the grant date and the Issuer having aggregate revenue of $150 million since the grant date, provided that the reporting person remains in service with the Issuer on the applicable vesting date."}],"balance_after":242983,"source":{"system":"sec-edgar","filing":"0001123292-26-000990","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011765/000112329226000990/form4.xml","form_type":"4"}},{"id":969727,"issuer":{"id":7276,"kind":"organization","name":"Tevogen Inc.","symbol":"TVGN"},"owners":[{"id":31015,"kind":"person","name":"Desai Kirti","position":1,"cik":"0002011765","reported_name":"Desai Kirti","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-15T17:31:50.000Z","date":"2025-12-11","kind":"gift","planned":false,"acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a gift of 100,000 shares of common stock to Shrimad Rajchandra Love and Care USA, Inc. and 200,000 shares of common stock to Shrimad Rajchandra Mission Dharampur (USA), Inc., which are charitable entities."}],"balance_after":10149186,"source":{"system":"sec-edgar","filing":"0001123292-25-000757","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011765/000112329225000757/form4.xml","form_type":"4"}},{"id":1098096,"issuer":{"id":7276,"kind":"organization","name":"Tevogen Inc.","symbol":"TVGN"},"owners":[{"id":31015,"kind":"person","name":"Desai Kirti","position":1,"cik":"0002011765","reported_name":"Desai Kirti","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-01T16:48:42.000Z","date":"2025-06-27","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan, which will vest ratably in three equal annual installments commencing on June 27, 2030, provided that the reporting person remains in service with the Issuer at such dates."}],"balance_after":10449186,"source":{"system":"sec-edgar","filing":"0001062993-25-012327","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011765/000106299325012327/form4.xml","form_type":"4"}},{"id":1480999,"issuer":{"id":7276,"kind":"organization","name":"Tevogen Inc.","symbol":"TVGN"},"owners":[{"id":31015,"kind":"person","name":"Desai Kirti","position":1,"cik":"0002011765","reported_name":"Desai Kirti","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-13T16:30:24.000Z","date":"2024-06-12","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":0.82,"value":2460.0,"ownership":{"direct":true},"balance_after":9699186,"source":{"system":"sec-edgar","filing":"0001062993-24-012592","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011765/000106299324012592/form4.xml","form_type":"4"}},{"id":1638697,"issuer":{"id":7276,"kind":"organization","name":"Tevogen Inc.","symbol":"TVGN"},"owners":[{"id":31015,"kind":"person","name":"Desai Kirti","position":1,"cik":"0002011765","reported_name":"Desai Kirti","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-16T17:30:03.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":9696186,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 14, 2024, pursuant to that certain Agreement and Plan of Merger, dated as of June 28, 2023, by and among the Issuer, Semper Merger Sub, Inc., and Tevogen Bio Inc (\"Tevogen\"), each issued and outstanding share of common stock of Tevogen was automatically cancelled and converted into approximately 4.8481 shares of the common stock of the Issuer."}],"balance_after":9696186,"source":{"system":"sec-edgar","filing":"0001062993-24-003497","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011765/000106299324003497/form4.xml","form_type":"4"}}]}